Overview of Biologic Agents in Pediatric Rheumatology
In recent years, significant progress has been made in understanding the pathogenesis of diseases in the field of pediatric rheumatology. In conjunction with advancements in immunology and biology, the elucidation of mechanisms in rheumatic diseases has led to the use of biological agents in their treatment. The scope of applications for biological drugs is expanding, with new treatment options and molecules being added each year. Therefore, it is crucial to have a good understanding of the mechanisms of action, appropriate usage, as well as the side effects and safety profiles of these agents.
This book aims to address various aspects of biological agents used in pediatric rheumatology practice, delving into the detailed examination of their mechanisms of action, clinical applications, and safety profiles. I express my gratitude to all the professors and colleagues who have contributed to and worked on the creation of this book.
I hope that this book serves as a valuable resource for young colleagues dedicated to pediatric rheumatology.
Sincerely.
Assoc. Prof. Dr. Halide Özge BAŞARAN
Editor
Hacettepe University Faculty of Medicine, Department of Pediatric Rheumatology, Ankara, Türkiye
Bölümler
Overview of Biologic Agents in Pediatric Rheumatology
Veysel ÇAM, Halide Özge BAŞARAN
Çam V, Başaran HÖ. Overview of biologic agents in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.1-4.
Biosimilars in Pediatric Rheumatology
Dilara ÜNAL, Emil ALİYEV, Yelda BİLGİNER
Ünal D, Aliyev E, Bilginer Y. Biosimilars in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.5-9.
Tumor Necrosis Factor Alpha Inhibitors in Pediatric Rheumatology
Selahaddin CEVİZBAŞ, Tuncay AYDIN, Şevket Erbil ÜNSAL
Cevizbaş S, Aydın T, Ünsal ŞE. Tumor necrosis factor alpha inhibitors in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.10-7.
Interleukin-1 Targeted Therapies in Pediatric Rheumatology
Yağmur BAYINDIR, Ezgi Deniz BATU AKAL, Seza ÖZEN
Bayındır Y, Batu Akal ED, Özen S. Interleukin-1 targeted therapies in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.18-27.
Interleukin-6 Targeted Therapies in Pediatric Rheumatology
Nergis AKAY, Ümit GÜL, Sezgin ŞAHİN
Akay N, Gül Ü, Şahin S. Interleukin-6 targeted therapies in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.28-31.
B-Cell Targeted Therapies in Pediatric Rheumatology
Gülşah KAVRUL KAYAALP, Nuray AKTAY AYAZ
Kavrul Kayaalp G, Aktay Ayaz N. B-cell targeted therapies in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.32-9.
Kinase Inhibitors in Pediatric Rheumatology
Nimet ÖNER, Banu ÇELİKEL ACAR
Öner N, Çelikel Acar B. Kinase inhibitors in pediatric rheumatology. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.40-7.
Other Molecules in Pediatric Rheumatology (T-Cell Co-Stimulation Blockade Interleukin-17, Interleukin-23 and Interferon-Gamma Targeted Therapies)
Şeyma TÜRKMEN, Betül SÖZERİ
Türkmen Ş, Sözeri B. Other molecules in pediatric rheumatology (T-cell co-stimulation blockade, interleukin-17, interleukin-23 and interferon-gamma targeted therapies). In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.48-54.
Hypersensitivity Reactions to Biologic Drugs in Children with Rheumatologic Disease
Cansu ÖZDEMİRAL, Özge SOYER
Özdemiral C, Soyer Ö. Hypersensitivity reactions to biologic drugs in children with rheumatologic disease. In: Başaran HÖ, ed. Overview of Biologic Agents in Pediatric Rheumatology. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.55-62.